Kaken Pharmaceutical to Invest $7 Million in Venture Capital Fund

Venture Capital


MT Newswires 2022

All news about KAKEN PHARMACEUTICAL CO., LTD.

Sales 2023 71 500 M
490 M
490 M
Net income 2023 10 800 M
74,0 M
74,0 M
Net Debt 2023 –
–
–
P/E ratio 2023 13,1x
Yield 2023 3,98%
Capitalization 141 B
966 M
966 M
Capi. / Sales 2023 1,97x
Capi. / Sales 2024 2,03x
Nbr of Employees 1 164
Free-Float 68,7%

Chart KAKEN PHARMACEUTICAL CO., LTD.



Duration :


Period :




Kaken Pharmaceutical Co., Ltd. Technical Analysis Chart | MarketScreener

Technical analysis trends KAKEN PHARMACEUTICAL CO., LTD.

Short Term Mid-Term Long Term
Trends Bearish Neutral Neutral




Income Statement Evolution

Sell

Buy
Mean consensus UNDERPERFORM
Number of Analysts 1
Last Close Price 3 765,00 JPY
Average target price 3 200,00 JPY
Spread / Average Target -15,0%


Credit: Source link

TVC Editorial Team 42890 posts

TVC is an online news portal that aims to provide the latest tech news, AI, fintech, robotics, cybersecurity, startups, venture capital, and much more!

You might also like More from author

Comments are closed.